Show simple item record

dc.creatorFontana, Stefano
dc.creatorButtinelli, Gabriele
dc.creatorFiore, Stefano
dc.creatorAmato, Concetta
dc.creatorPataracchia, Marco
dc.creatorKota, Majlinda
dc.creatorAćimović, Jela
dc.creatorBlažević, Mia
dc.creatorMulaomerović, Mirsada
dc.creatorNikolaeva-Glomb, Lubomira
dc.creatorMentis, Andreas
dc.creatorVoulgari-Kokota, Androniki
dc.creatorGashi, Luljeta
dc.creatorKaçaniku-Gunga, Pranvera
dc.creatorBarbara, Christopher
dc.creatorMelillo, Jackie
dc.creatorProtić, Jelena
dc.creatorFilipović-Vignjević, Svetlana
dc.creatorO’Connor, Patrick M.
dc.creatorD’Alberto, Alessandra
dc.creatorOrioli, Riccardo
dc.creatorSiddu, Andrea
dc.creatorSaxentoff, Eugene
dc.creatorStefanelli, Paola
dc.date.accessioned2022-02-22T09:14:27Z
dc.date.available2022-02-22T09:14:27Z
dc.date.issued2022
dc.identifier.issn2076-393X
dc.identifier.urihttp://intor.torlakinstitut.com/handle/123456789/618
dc.description.abstractHere we analyzed six years of acute flaccid paralysis (AFP) surveillance, from 2015 to 2020, of 10 countries linked to the WHO Regional Reference Laboratory, at the Istituto Superiore di Sanità, Italy. The analysis also comprises the polio vaccine coverage available (2015–2019) and enterovirus (EV) identification and typing data. Centralized Information System for Infectious Diseases and Laboratory Data Management System databases were used to obtain data on AFP indicators and laboratory performance and countries’ vaccine coverage from 2015 to 2019. EV isolation, identification, and typing were performed by each country according to WHO protocols. Overall, a general AFP underreporting was observed. Non-Polio Enterovirus (NPEV) typing showed a high heterogeneity: over the years, several genotypes of coxsackievirus and echovirus have been identified. The polio vaccine coverage, for the data available, differs among countries. This evaluation allows for the collection, for the first time, of data from the countries of the Balkan area regarding AFP surveillance and polio vaccine coverage. The need, for some countries, to enhance the surveillance systems and to promote the polio vaccine uptake, in order to maintain the polio-free status, is evident.
dc.languageen
dc.publisherMDPI
dc.relationWHO grant “Full providing of laboratory support for surveillance of polioviruses in Acute Flaccid Paralysis Cases and in the Environment from specified European Countries” (June 2018–November 2019)
dc.relationItalian Ministry of Health CCM 4S11 Grant, “Monitoraggio della circolazione di enterovirus a supporto delle attività di sorveglianza per il mantenimento dello status polio-free” (February 2019–Febraury 2021)
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceVaccines
dc.subjectacute flaccid paralysis
dc.subjectenterovirus
dc.subjectnon-polio enteroviruses
dc.subjectpolio vaccine coverage
dc.subjectpoliovirus
dc.subjectpoliovirus surveillance
dc.titleRetrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece
dc.typearticleen
dc.rights.licenseBY
dc.citation.issue1
dc.citation.rankM21
dc.citation.spage44
dc.citation.volume10
dc.identifier.doi10.3390/vaccines10010044
dc.identifier.fulltexthttp://intor.torlakinstitut.com/bitstream/id/1275/vaccines-10-00044.pdf
dc.identifier.scopus2-s2.0-85122150240
dc.identifier.wos000759101400001
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record